The EZ-BAA program and seeks abstract submissions for select COVID-19 medical countermeasures
Enhancing the Nation's PUBLIC HEALTH SECURITY and emergency preparedness
by facilitating communication on innovative products and solutions between federal agencies
and public stakeholders.
Biomedical Advanced Research and Development Authority
BARDA provides a systematic approach to the development and purchase of the necessary vaccines, drugs,
therapies, and diagnostic tools for public health medical emergencies.
ASPR focuses on preparedness planning and response; building federal emergency medical operational
capabilities; countermeasures research, and grants to strengthen the capabilities of health care systems to minimize the health impacts of public health emergencies.
NIH is responsible for conducting research to better understand public health threats and establish a
foundation for developing medical countermeasures.
FDA's responsibility is to ensure that medical countermeasures (MCMs)-such as drugs, vaccines, and diagnostic
tests-to counter these threats are safe, effective, and secure.
The CDC leads the emergency preparedness and response activities by providing strategic coordination for
activities across local, state, national, and international public health partners.
The DHS is charged with securing the nation from the many threats we face. These threats include natural and
man-made biological, chemical, radiological, and nuclear threats.
Website Refresh - www.medicalcountermeasures.gov is pleased to announce a phased launch of our newly redesigned
public website. We are making website improvements to provide a more modern and customer-centric
web experience. Over the next several months you will see differences throughout the site while we
continue implementing updates. Thank you for your understanding and please let us know if you have
any questions: techwatchinbox@hhs.gov